You just read:

Intas Becomes the First to Launch Romiplostim in India, Significantly Reducing the Treatment Cost of Chronic Immune Thrombocytopenia (ITP)

News provided by

Intas Pharmaceuticals Ltd.

09 Jul, 2019, 14:49 IST